Total Funding
68
57
Total FundingSeed raised
Growth Score
-10 pts
Heat Score
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
161263
RION is a clinical-stage regenerative medicine company.
- Atta Behfar: Co-FounderPast Role: Celyad, Special Scientific Advisor
- Scott Rosenow: Co-Founder and Chief Administrative Officer
About the Company
Rion is a clinical-stage biotechnology company That develops exosome therapeutics. Purified Exosome ProductTM (PEPTM) from Rion is a potent, useful, and easily available regenerative medicine. Research by Rion and its scientific partners has demonstrated the potential of PEP to repair a variety of injured tissue, including tendons, muscles, and
skin. The goal of Rion is to spread the use of clinically effective regenerative medicine throughout the world.
